The drug, a reformulation of buprenorphine, is essentially just a milder opioid that can blunt the symptoms of withdrawal while a person is being weaned off — competing variants of which are already generating nearly $900 million in U.S. sales.
Sackler's family also happens to own Purdue Pharma, the company that first developed OxyContin — a powerful narcotic painkiller that has been blamed for spurring the epidemic of opioid addiction that has decimated communities all across America.
In other words, Sackler made millions off of sales of a drug that caused a massive public health crisis — and now he stands to make millions more by selling the public a solution.
Purdue, one of several drug companies that made a decades-long push for liberal prescription of opioids, is currently facing a mountain of lawsuits. Prosecutors in several states allege Purdue was aware of the risk of addiction and overdose, but deceived doctors and patients and downplayed the risks to increase their sales — a charge the company denies. Massachusetts Attorney General Maura Healey directly names several members of the Sackler family as defendants.
The National Institute of Drug Abuse estimates that up to 12 percent of patients prescribed an opioid develop an abuse disorder, and as many as 6 percent eventually switch to heroin. More than 115 people a day are now killed by opioid overdoses.
While increased availability of addiction treatment is a good thing, it is not a solution to the epidemic. Opioids remain a necessary tool to treat severe pain from surgery, cancer, and other serious conditions, but they must be used judiciously, and alternative therapies must be made available — particularly in lower-income rural areas where people are at higher risk.
Enjoy this piece?
… then let us make a small request. AlterNet’s journalists work tirelessly to counter the traditional corporate media narrative. We’re here seven days a week, 365 days a year. And we’re proud to say that we’ve been bringing you the real, unfiltered news for 20 years—longer than any other progressive news site on the Internet.
It’s through the generosity of our supporters that we’re able to share with you all the underreported news you need to know. Independent journalism is increasingly imperiled; ads alone can’t pay our bills. AlterNet counts on readers like you to support our coverage. Did you enjoy content from David Cay Johnston, Common Dreams, Raw Story and Robert Reich? Opinion from Salon and Jim Hightower? Analysis by The Conversation? Then join the hundreds of readers who have supported AlterNet this year.
Every reader contribution, whatever the amount, makes a tremendous difference. Help ensure AlterNet remains independent long into the future. Support progressive journalism with a one-time contribution to AlterNet, or click here to become a subscriber. Thank you. Click here to donate by check.